Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03915717 · ClinicalTrials.gov registry record
Observational Study of Outcomes After EchoMark and EchoSure-based Free Flap Monitoring
A clinical trial, sponsored by Sonavex.
- Terminated
- Registry status
- 14
- Enrollment target
NCT03915717: Clinical Trial study, sponsored by Sonavex.
NCT03915717 is a clinical trial that was terminated before completion, run by Sonavex. The registered enrollment target is 14 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03915717 was terminated before completion, sponsored by Sonavex.
- TERMINATED
- Registry status
- 14 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the performance of the EchoMark and EchoSure as an ultrasound-based method of monitoring the viability of free flaps and patency of at-risk vessels.
Primary Outcome
Surgeon evaluation of improved monitoring ability via questionnaire with likert scale
Interventions
- DEVICE EchoMark
- DEVICE EchoSure
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 14 participants |
| Start Date | 2019-09-19 |
| Est. Completion | 2022-05-05 |
Why NCT03915717 stopped before completion
NCT03915717 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 14 participants, a relatively small participant target.
The record links to 0 conditions, and to 2 interventions - of which EchoMark is the first listed.
NCT03915717 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03915717 about?
NCT03915717 is a clinical study titled "Observational Study of Outcomes After EchoMark and EchoSure-based Free Flap Monitoring". The purpose of this study is to evaluate the performance of the EchoMark and EchoSure as an ultrasound-based method of monitoring the viability of free flaps and patency of at-risk vessels.
What is the current status of trial NCT03915717?
This trial is currently terminated. The enrollment target is 14 participants. The study started on 2019-09-19. Estimated completion is 2022-05-05.
What interventions are being tested in trial NCT03915717?
The interventions under investigation include: EchoMark (DEVICE), EchoSure (DEVICE).
Who is sponsoring clinical trial NCT03915717?
This trial is sponsored by Sonavex, which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02523092 · 14 participants · Phase 4
Use of CXCL9 as a Biomarker of Acthar Efficacy
- NCT04263285 · 14 participants · NA
Treatment of Depression Post-SCI
- NCT04743271 · 14 participants · NA
Food and Circadian Timing
- NCT05065671 · 14 participants · Phase 1
Microbiome Derived Metabolism and Pharmacokinetics
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT06358040 · started 2026-10 · NA
Opioid Dispenser for Microdiscectomy/Laminectomy